Mitesh J. Borad, M.D.

  1. Oncologist

Departments

Location

  1. Phoenix, Arizona

Languages

English
  • Phase I drug development
  • Pancreatic cancer
  • Biliary cancer (cholangiocarcinoma)
  • Liver cancer (hepatocellular carcinoma)
  • Genomic/novel clinical trial designs
  • Rare cancers: adrenocortical cancer, metastatic basal cell cancer, pheochromocytoma, gastrointestinal stromal tumor (GIST)
Phx

Phoenix, Arizona

  1. 2008
    Research Scholar - Drug Development Scholar/Genomics Medicine ScholarTranslational Genomics Research Institute
  2. 2005
    Fellow - Medical OncologyTulane University School of Medicine
  3. 2003
    Resident - Internal MedicineCedars-Sinai Medical Center
  4. 2000
    MDUniversity of Medicine and Dentistry of New Jersey
  5. 1996
    BS - Biomedical Engineering (summa cum laude)Boston University

Certifications

  1. 2006
    Medical OncologyAmerican Board of Internal Medicine

Awards and honors

  1. 2014
    New Innovator AwardNational Institutes of Health
  2. 2011
    Paul Calabresi Scholar in Clinical-Translational ResearchMayo Clinic
  3. 2003
    Solomon Scholar Research AwardCedars Sinai Medical Center
  4. 1999
    MemberTau Beta Pi, The Engineering Honor Society
  5. 1999
    MemberGolden Key International Honor Society
  6. 1999
    MemberNational Biomedical Engineering Honor Society
  7. 1992
    National Merit ScholarshipCentral Board of Secondary Education

Professional memberships

  1. 2020
    MemberNew Applications of Synthetic Biology to Cancer Workshop, National Institutes of Health
  2. 2020 - present
    MemberSomatic Genomic Panel Testing in Metastatic Disease Guideline Panel, American Society of Clinical Oncology
  3. 2020 - present
    Co-LeaderCholangiocarcinoma Eligibility Criteria Consistency Initiative, Office of Clinical Excellence (OCE), Food and Drug Administration (FDA)
  4. 2020 - present
    ChairInternational Cholangiocarcinoma Research Network (ICRN)
  5. 2020
    Grant ReviewerResearch Proposals, Cancer Research UK (CRUK)
  6. 2020
    Grant ReviewerCholangiocarcinoma Research Fellowship Program, The Cholangiocarcinoma Foundation
  7. 2020 - present
    MemberHepatobiliary Cancer Panel, National Cancer Center Network (NCCN)
  8. 2019 - present
    MemberResearch Operations Management Team (ROMT), Executive Operations Team
  9. 2019
    MemberGene Therapy Task Force, Enterprise Research Committee
  10. 2019
    Grant ReviewerResearch Proposals, Vidi Talent Program - Netherlands
  11. 2019
    Grant ReviewerCholangiocarcinoma Research Fellowship Program, The Cholangiocarcinoma Foundation
  12. 2018
    Grant ReviewerResearch Proposals, St. Baldrick's Osteosarcoma Research Program
  13. 2018
    Grant ReviewerCholangiocarcinoma Research Fellowship Program, The Cholangiocarcinoma Foundation
  14. 2017
    Grant ReviewerCholangiocarcinoma Research Fellowship Program, The Cholangiocarcinoma Foundation
  15. 2017 - present
    Director at LargeThe Arizona Clinical Oncology Society (TACOS)
  16. 2016 - 2020
    Vice ChairInternational Cholangiocarcinoma Research Network (ICRN)
  17. 2016
    Grant ReviewerCholangiocarcinoma Research Fellowship Program, The Cholangiocarcinoma Foundation
  18. 2016
    Grant ReviewerResearch Proposals, Italian Ministry of Health
  19. 2016 - present
    Vice ChairInternational Cholangiocarcinoma Research Network (ICRN)
  20. 2015 - 2021
    Standing MemberDrug Discovery and Molecular Pharmacology Study Section, National Institutes of Health
  21. 2015
    MemberAcelarin (NUC-1031) Development in Biliary Cancers Scientific Advisory Board, Nucana
  22. 2015
    MemberScientific Advisory Board, Pancreatic Cancer Pipeline Development, Pfizer
  23. 2015
    Grant ReviewerCholangiocarcinoma Research Fellowship Program, The Cholangiocarcinoma Foundation
  24. 2014
    MemberScientific Advisory Board, MET Pathway Development Program, Amgen, Inc.
  25. 2014 - present
    MemberCenter for Immunology and Immune Therapies
  26. 2014 - present
    MemberBiomarker Discovery Program
  27. 2014 - present
    MemberHepatobiliary and Pancreatic Cancer Specialty Council, Mayo Clinic Cancer Center
  28. 2014 - present
    MemberBasket/Umbrella Trial Workgroup, Mayo Clinic Cancer Center
  29. 2014 - present
    MemberThe Cancer Genome Atlas (TCGA) Cholangiocarcinoma Analysis Working Group, National Institutes of Health
  30. 2014 - present
    MemberClinical Science Advisory Board, The Cholangiocarcinoma Foundation
  31. 2013 - present
    MemberIndividualized Medicine Clinic Cancer Task Force, Mayo Clinic Center for Individualized Medicine
  32. 2013 - present
    MemberService Line 1 (Cancer) Leadership Team, Mayo Clinic Center for Individualized Medicine
  33. 2013 - present
    MemberGenomics Tumor Board, Mayo Clinic Center for Individualized Medicine
  34. 2012 - 2015
    Founding MemberHepatobiliary Cancer Research Consortium, CanLiv
  35. 2012 - 2015
    Board of DirectorsPancreatic Cancer Research Team, CanLiv
  36. 2012
    MemberScientific Advisory Board, PEGPH20 Pegylated Hyaluronidase Development Program, Halozyme Therapeutics
  37. 2012 - present
    MemberIndividualized Medicine Working Group, Mayo Clinic Center for Individualized Medicine
  38. 2012 - present
    MemberPhase I Administrative Team, Phase I Disease Oriented Group, Mayo Clinic Cancer Center
  39. 2012 - present
    ChairPhase I Disease Working Group, Cancer Clinical Research Office-ARZ
  40. 2010 - 2012
    MemberScientific Review Committee
  41. 2010 - 2012
    MemberScientific Progress Review Subcommittee, Mayo Clinic Cancer Center
  42. 2010 - 2012
    ChairExecutive Committee, Cancer Clinical Research Office-ARZ
  43. 2010 - 2012
    MemberExecutive Committee, Division of Hematology/Oncology, Department of Internal Medicine
  44. 2010 - 2012
    MemberClinical Research Subcommittee, Research Operations Management Team (ROMT), Executive Operations Team
  45. 2010 - present
    MemberCancer Center Research Committee, Research Operations Management Team (ROMT), Executive Operations Team
  46. 2009 - present
    ReviewerSmall Business Innovation Research Grants Meeting, National Institutes of Health
  47. 2009 - present
    MemberHepatobiliary Cancer Task Force, National Cancer Institute, National Institutes of Health
  48. 2008 - present
    MemberGI Cancer Disease Oriented Group, Mayo Clinic Cancer Center
  49. 2008 - present
    MemberPhase I Disease Oriented Group, Mayo Clinic Cancer Center
  50. 2008 - present
    MemberHepatocellular CA Management Conference
  51. 2008 - 2009
    MemberScientific Review Committee, American Society of Clinical Oncology
  52. 2008
    MemberScientific Advisory Board, Smoothened/Hedgehog Inhibitor Program, Merck & Company Pharmaceutical Company
  53. 2008 - present
    MemberPancreatic Cancer Management Conference